This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Cell Therapeutics, Inc.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Gianluca Pardi: Innovator in Antitumor Compounds and Poly-α-Glutamic Acid
Introduction
Gianluca Pardi is a notable inventor based in Ripafratta, Italy. He has made significant contributions to the field of chemistry, particularly in the development of antitumor compounds and innovative processes for synthesizing poly-α-glutamic acid. With a total of 2 patents, his work has the potential to impact medical and pharmaceutical applications.
Latest Patents
Gianluca Pardi's latest patents include a groundbreaking invention titled "Bis-platinum complexes with antitumor activity." This compound features a general formula that allows for various substitutions, making it versatile in its application against tumors. Another significant patent is the "Process for the preparation of poly-α-glutamic acid and derivatives thereof." This invention outlines an improved method for synthesizing poly-α-glutamic acids, enabling precise control over the molecular weight of the resulting compounds.
Career Highlights
Throughout his career, Gianluca has worked with prominent organizations, including Cell Therapeutics, Inc. and its secondary office. His expertise in chemistry and innovative approaches have positioned him as a valuable contributor to the field.
Collaborations
Gianluca has collaborated with esteemed colleagues such as Mario Grugni and Alberto Bernareggi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in their respective fields.
Conclusion
Gianluca Pardi's contributions to the field of chemistry, particularly in antitumor compounds and poly-α-glutamic acid synthesis, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical applications and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile